4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-24-009538
Chief Financial Officer gave up 2,175 shares (to pay taxes)
- Chief Financial Officer acquired 4,621 shares (grant or award)
- Chief Financial Officer acquired 9,275 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisenstadt Richard I Chief Financial Officer | 2024-01-30 | Option exercise | +9,275 | 42,566 | D: show line 1 in the form | ||
| Eisenstadt Richard I Chief Financial Officer | 2024-01-30 | Shares withheld for taxes | −2,175 | $9.80 | $21,315 | 40,391 | D: show line 2 in the form |
| Eisenstadt Richard I Chief Financial Officer | 2024-01-31 | Grant or award | +4,621 | $2.69 | $12,430 | 45,012 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Eisenstadt Richard I Chief Financial Officer | 2024-01-30 | Option exercise · Restricted Stock Units | −9,275 | 27,825 | D: show line 4 in the form |
Loading xslF345X05/tm244961-1_4seq1.xml…